These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16006264)

  • 21. Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction.
    Cavusoglu E; Ruwende C; Chopra V; Yanamadala S; Eng C; Clark LT; Pinsky DJ; Marmur JD
    Am Heart J; 2006 May; 151(5):1101.e1-8. PubMed ID: 16644343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel inflammatory biomarkers in acute coronary syndrome.
    Sim DS; Ahn Y
    Korean J Intern Med; 2013 Mar; 28(2):156-8. PubMed ID: 23526870
    [No Abstract]   [Full Text] [Related]  

  • 23. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.
    Derosa G; D'Angelo A; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo S; Montagna L; Gravina A; Ferrari I; Galli S; Paniga S; Tinelli C; Cicero AF
    Endothelium; 2006; 13(3):227-31. PubMed ID: 16840178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P
    Clin Cardiol; 2009 May; 32(5):288. PubMed ID: 19452490
    [No Abstract]   [Full Text] [Related]  

  • 25. Variations with time of plasma concentrations of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2.
    Rossignol P; Jacob MP; Cambillau M; Mouradian D; Plouin PF; Chatellier G
    Thromb Res; 2007; 119(2):261-3. PubMed ID: 16530811
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.
    Eldrup N; Kragelund C; Steffensen R; Nordestgaard BG
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):677-83. PubMed ID: 21194909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interrelationship of Matrix Metalloproteinase-9 and Its Tissue Inhibitor-1 and Blood Lipid Profile of Patients With Carotid Atherosclerosis].
    Usmanova ZA; Rosykhodzhaeva GA
    Kardiologiia; 2015; 55(9):57-8. PubMed ID: 26898096
    [No Abstract]   [Full Text] [Related]  

  • 28. Cut-off values for serum matrix metalloproteinase-9: is there a threshold to predict renal involvement for Henoch-Schonlein purpura in children?
    Qin YH; Zhou TB; Lei FY; Huang WF; Zhao YJ; Lin FQ; Su LN
    Nephrology (Carlton); 2011 Jan; 16(1):93-9. PubMed ID: 21175984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
    Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum or plasma: what kind of blood sample should be used to measure circulating matrix metalloproteinases and their inhibitors?
    Jung K
    J Neuroimmunol; 2005 May; 162(1-2):1-2. PubMed ID: 15833353
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis.
    Palus M; Zampachová E; Elsterová J; Růžek D
    J Infect; 2014 Feb; 68(2):165-9. PubMed ID: 24091083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-analytical conditions for the assessment of circulating MMP-9 and TIMP-1: consideration of pitfalls.
    John M; Jung K
    Eur Respir J; 2005 Aug; 26(2):364-5; author reply 365-6. PubMed ID: 16055891
    [No Abstract]   [Full Text] [Related]  

  • 33. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy.
    Ichiyama T; Morishima T; Kajimoto M; Matsushige T; Matsubara T; Furukawa S
    Pediatr Infect Dis J; 2007 Jun; 26(6):542-4. PubMed ID: 17529876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of MMP-9 to TIMP-1 ratio with long-term body weight and waist circumference after dietary weight reduction in men with metabolic syndrome.
    Lee CL; Wang JS; Lee IT; Fu CP; Lee WJ; Liang KW; Lin SY; Li YF; Sheu WH
    Clin Chim Acta; 2016 Jan; 452():182-4. PubMed ID: 26626455
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of shuxuening injection on the levels of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in acute exacerbated chronic obstructive pulmonary disease patients].
    Wang TJ; Xie ZH; Zhao ZZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):191-4. PubMed ID: 22574591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases-2, -9 and tissue inhibitor of metallo-proteinase-1 in lung cancer invasion and metastasis.
    Ming SH; Sun TY; Xiao W; Xu XM
    Chin Med J (Engl); 2005 Jan; 118(1):69-72. PubMed ID: 15642229
    [No Abstract]   [Full Text] [Related]  

  • 37. Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis.
    Ozçaka O; Biçakci N; Pussinen P; Sorsa T; Köse T; Buduneli N
    Oral Dis; 2011 Jan; 17(1):68-76. PubMed ID: 20646231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in acute pancreatitis.
    Wereszczynska-Siemiatkowska U; Siemiatkowski A; Swidnicka-Siergiejko A; Mroczko B; Dabrowski A
    Z Gastroenterol; 2015 Mar; 53(3):199-204. PubMed ID: 25775169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia.
    Sunagawa S; Ichiyama T; Honda R; Fukunaga S; Maeba S; Furukawa S
    Brain Dev; 2009 Sep; 31(8):588-93. PubMed ID: 18849127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in patients with familial Mediterranean fever.
    Dinç M; Tanoğlu A; Yazgan Y; Beyazıt Y; Öncü K; Önem Y; Hıra S; Kaplan M; Küçük İ; Sakın YS; Demirtürk L
    Turk J Gastroenterol; 2015 Nov; 26(6):487-91. PubMed ID: 26510088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.